Product Information

ASMANEX TWISTHALER 110 MCG #30 is a brand product labeled by Organon LLC, priced at $88.8609 per EA under NDC 78206011501. Its NADAC has been published 255 times since Oct 6, 2021.

FDA first approved this application on Mar 30, 2005.

The High Outlier badge above means this manufacturer's average price in the Mometasone Furoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ASMANEX TWISTHALER 110 MCG #30

Mometasone Furoate
$88.8609per EA
High Outlier

Strength

110 ug/1

Manufacturer

Organon LLC

NDC

78206011501

Classification

Brand

Dosage Form

INHALANT

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

MOMETASONE FUROATE

Approval Type

New Drug (NDA)

FDA Application

NDA021067

FDA Approved

3/30/2005

On Market Since

6/1/2021

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for ASMANEX TWISTHALER 110 MCG #30 has been published 255 times since Oct 6, 2021, and over the history we have for it it has declined 47.8%. The table below summarizes its recorded NADAC range and movement.

Current price$88.8609 per EA
All-time high$178.6480 (Jan 3, 2024)
All-time low$88.8609 (Aug 19, 2026)
52-week high$89.0452
52-week low$88.8609
Median price$89.4011
Average price$130.0754
Largest weekly change-50.0% (Jan 10, 2024)
Weeks tracked255
Tracking sinceOct 6, 2021

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.2%

3Y

-50.3%

5Y

N/A

All

-47.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Mometasone Furoate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ASMANEX TWISTHALER 110 MCG #30?

The current National Average Drug Acquisition Cost (NADAC) for ASMANEX TWISTHALER 110 MCG #30, manufactured by Organon LLC, is $88.8609 per EA (NDC 78206011501), effective Aug 19, 2026.

How has the price of ASMANEX TWISTHALER 110 MCG #30 changed over time?

Over the history we have for it, the NADAC for ASMANEX TWISTHALER 110 MCG #30 has declined 47.8%. It has been tracked across 255 weekly CMS publications since Oct 6, 2021.

What are the highest and lowest recorded NADAC prices for ASMANEX TWISTHALER 110 MCG #30?

Since Oct 6, 2021, the NADAC for ASMANEX TWISTHALER 110 MCG #30 has ranged from a low of $88.8609 (Aug 19, 2026) to a high of $178.6480 (Jan 3, 2024), with a median of $89.4011 per EA.

Are there cheaper alternatives to ASMANEX TWISTHALER 110 MCG #30?

No other NADAC-published product currently shares the active ingredient and strength of ASMANEX TWISTHALER 110 MCG #30 in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ASMANEX TWISTHALER 110 MCG #30?

ASMANEX TWISTHALER 110 MCG #30 (NDC 78206011501) is labeled by Organon LLC, and CMS classifies it as a brand product.